Filter News
Area of Research
- (-) Materials for Computing (3)
- (-) Neutron Science (9)
- Advanced Manufacturing (1)
- Biology and Environment (14)
- Clean Energy (18)
- Computational Biology (1)
- Fusion and Fission (6)
- Fusion Energy (7)
- Materials (8)
- National Security (3)
- Nuclear Science and Technology (12)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Supercomputing (15)
News Topics
- (-) Advanced Reactors (1)
- (-) Coronavirus (11)
- 3-D Printing/Advanced Manufacturing (10)
- Artificial Intelligence (6)
- Big Data (2)
- Bioenergy (7)
- Biology (6)
- Biomedical (13)
- Biotechnology (1)
- Chemical Sciences (6)
- Clean Water (2)
- Climate Change (2)
- Composites (2)
- Computer Science (18)
- Cybersecurity (1)
- Decarbonization (3)
- Energy Storage (10)
- Environment (9)
- Fossil Energy (1)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (2)
- Isotopes (1)
- Machine Learning (3)
- Materials (24)
- Materials Science (35)
- Mathematics (1)
- Microscopy (7)
- Nanotechnology (17)
- National Security (3)
- Neutron Science (101)
- Nuclear Energy (3)
- Physics (9)
- Polymers (7)
- Quantum Computing (1)
- Quantum Science (9)
- Security (2)
- Simulation (1)
- Space Exploration (3)
- Summit (6)
- Sustainable Energy (7)
- Transportation (9)
Media Contacts
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
Oak Ridge National Laboratory researchers collaborated with Iowa State University and RJ Lee Group to demonstrate a safe and effective antiviral coating for N95 masks. The coating destroys the COVID-19-causing coronavirus and could enable reuse of masks made from various fabrics.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
When COVID-19 was declared a pandemic in March 2020, Oak Ridge National Laboratory’s Parans Paranthaman suddenly found himself working from home like millions of others.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Collaborators at Oak Ridge National Laboratory and the University of Tennessee Health Science Center are developing a breath-sampling whistle that could make COVID-19 screening easy to do at home.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
The Department of Energy’s Office of Science has selected three Oak Ridge National Laboratory scientists for Early Career Research Program awards.